Skip to content

Oscar Soto-Angona

9 papers in the library · 43 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy.

Natural Product Research June 2, 2026 Genís Ona, Cristina Llagostera, Oscar Alvarez et al.

Psilocybin, the main psychoactive compound in Psilocybe cubensis mushrooms, has gained considerable attention for its therapeutic potential. Current research focuses only on isolated psilocybin, neglecting the broader pharmacological and cultural use of the whole mushroom. This perspective advocates for an integrative approach that includes standardised P. cubensis extracts within the...

Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies

Discover Mental Health March 19, 2026 Àlvar Farré-colomés, Olga Rublinetska, Oscar Soto-Angona

Psilocybin-assisted therapies are innovative therapeutic approaches, particularly in the treatment of depression. However, there are sparse studies providing functional magnetic resonance imaging (fMRI) evidence elucidating the underlying biological mechanisms that support clinical outcomes. This review aims to comprehensively gather all the evidence reported in psilocybin studies using fMRI...

Current perspectives on psychedelic treatments in Europe.

Lancet Reg Health Eur November 20, 2025 Santiago Madero, Oscar Soto-Angona, Genís Ona et al. 9 citations

In this viewpoint, we explore the evolving landscape of psychedelic-assisted therapy in Europe, focusing on clinical, regulatory, and therapeutic developments. While access remains limited, recent initiatives in Switzerland, Germany, and the Czech Republic illustrate growing momentum toward regulated use. We examine the debate surrounding psychedelics as pharmacological agents versus...

Ayahuasca-assisted meaning reconstruction therapy as an early resource for bereavement: a non-randomized clinical trial.

Scientific Reports September 1, 2025 Oscar Soto-Angona, Óscar Andión, Pablo Sabucedo et al. 3 citations

Preliminary evidence suggests that ayahuasca may alleviate severe grief symptoms. This three-arm, sequentially allocated, open-label study examines the therapeutic changes associated with ayahuasca-assisted meaning reconstruction therapy (A-MR) compared to meaning reconstruction therapy alone (MR) and a no-treatment control (NT). A total of 84 adults experiencing severe grief within 12 months...

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.

Neuroscience of Consciousness 2025 Christopher Timmermann, James W. Sanders, David Reydellet et al. 19 citations

5-MeO-DMT is a short-acting psychedelic that is anecdotally reported to induce a radical disruption of the self and a paradoxical quality of aroused, waking awareness that is nevertheless devoid of any specific perceptual contents. Here, we conducted an exploratory observational study of the phenomenological and neuronal effects of this compound. We collected micro-phenomenological interviews,...

Corrigendum: Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol.

Frontiers in Psychiatry 2025 Pablo Sabucedo, Óscar Andión, Robert A Neimeyer et al. correction

1 IntroductionGrieving the death of a loved one is a nearly universal experience, and one which may be experienced multiple times over the course of a lifetime. Recent studies have shown that, for each death, approximately nine relatives are directly affected (1). The loss of a first-degree family member significantly increases the risk of mortality, disease, and suicide for the mourner (2–6)....

Do classic psychedelics increase the risk of seizures? A scoping review.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology August 1, 2024 Oscar Soto-Angona, Adriana Fortea, Lydia Fortea et al. 7 citations

Seizures are a concerning adverse event frequently associated with the use of psychedelics, and hence, studies involving these substances tend to exclude patients with past history of epilepsy. This is especially relevant because epileptic seizures are markedly increased in the population suffering from mental disorders, and psychedelic assisted therapy is being researched as a promising...

Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol.

Frontiers in Psychiatry 2024 Pablo Sabucedo, Óscar Andión, Robert A Neimeyer et al. 4 citations

Psychotherapy for Prolonged Grief Disorder (PGD), a condition characterized by an intense and persistent grief response, has received increased attention over the past decades. Evidence-based approaches to prevent PGD are currently scarce, and not always effective. This paper introduces a protocol for a clinical trial exploring the effectiveness of a Meaning Reconstruction psychotherapy...